Potential of Fibrin Glue and Mesenchymal Stem Cells (MSCs) to Regenerate Nerve Injuries: A Systematic Review
Nenhuma Miniatura disponível
Data
2022-01-01
Autores
Ortiz, Adriana de Cássia
Fideles, Simone Ortiz Moura
Pomini, Karina Torres
Bellini, Márcia Zilioli
Pereira, Eliana de Souza Bastos Mazuqueli
Reis, Carlos Henrique Bertoni
Pilon, João Paulo Galletti [UNESP]
de Marchi, Miguel Ângelo
Trazzi, Beatriz Flavia de Moraes
da Silva, Willian Saranholi
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Cell-based therapy is a promising treatment to favor tissue healing through less invasive strategies. Mesenchymal stem cells (MSCs) highlighted as potential candidates due to their angio-genic, anti-apoptotic and immunomodulatory properties, in addition to their ability to differentiate into several specialized cell lines. Cells can be carried through a biological delivery system, such as fibrin glue, which acts as a temporary matrix that favors cell-matrix interactions and allows local and paracrine functions of MSCs. Thus, the aim of this systematic review was to evaluate the potential of fibrin glue combined with MSCs in nerve regeneration. The bibliographic search was performed in the PubMed/MEDLINE, Web of Science and Embase databases, using the descriptors (“fibrin sealant” OR “fibrin glue”) AND “stem cells” AND “nerve regeneration”, considering articles published until 2021. To compose this review, 13 in vivo studies were selected, according to the eligibility criteria. MSCs favored axonal regeneration, remyelination of nerve fibers, as well as promoted an increase in the number of myelinated fibers, myelin sheath thickness, number of axons and expression of growth factors, with significant improvement in motor function recovery. This systematic review showed clear evidence that fibrin glue combined with MSCs has the potential to regenerate nervous system lesions.
Descrição
Palavras-chave
Fibrin glue, Fibrin sealant, Nerve regeneration, Scaffolds, Stem cells, Systematic review
Como citar
Cells, v. 11, n. 2, 2022.